Patient guide · Urology
Bladder biopsy, rigid cystoscopy with biopsy or TURBT for bladder cancer diagnosis and staging.
A bladder biopsy is performed under rigid cystoscopy — either as a small forceps biopsy or a full transurethral resection of the bladder tumour (TURBT). It is the diagnostic and initial-treatment procedure for bladder cancer.
Why patients choose us
- 01
The right hands
We route you to a consultant urologist who does bladder cancer surgery week-in, week-out — not a generalist.
- 02
Diagnosis and treatment in one
TURBT samples the tumour, resects it, and gives the T-stage in a single anaesthetic.
- 03
Independent, and free
We are paid by no clinic, so the recommendation is impartial and costs you nothing.
Key facts
What a bladder biopsy is, at a glance.
The essentials before your admission — anaesthetic, cold-cup vs TURBT, and what post-op treatment usually follows.
-
Definition
Cystoscopic sampling or resection of bladder tissue.
-
Anaesthetic
Rigid cystoscopy under GA or spinal.
-
Cold-cup biopsy
For suspicious flat lesions or CIS.
-
TURBT
For visible tumours — diagnostic and therapeutic.
-
Staging
Provides depth-of-invasion for T-staging.
-
Post-op
Single-dose intravesical mitomycin reduces recurrence.
Preparation and steps
From consultation to written report — what happens, in order.
A day-case procedure with an overnight catheter for most patients. One consultant urologist plans, performs and reports.
- 01
Urology consultation
A consultant urologist reviews your symptoms, haematuria work-up and any prior imaging.
- 02
Flexible cystoscopy first (usually)
An awake outpatient look inside the bladder locates and characterises the lesion.
- 03
Pre-op MSU
A mid-stream urine sample rules out active infection before theatre.
- 04
Fast 6 hours pre-procedure
Nothing to eat for 6 hours; clear fluids up to 2 hours before, per anaesthetic protocol.
- 05
Rigid cystoscopy under GA / spinal
You are asleep or numb from the waist down while a rigid scope enters the bladder.
- 06
Cold-cup biopsy or TURBT
Forceps biopsy for flat lesions, or transurethral resection for visible tumours.
- 07
Post-op catheter and bladder washout
A catheter drains and washes the bladder overnight, usually removed the next morning.
What it shows
What a bladder biopsy can, and can’t, tell us.
The histology drives everything — tumour type, grade, depth of invasion and lymphovascular status decide the risk category and the treatment pathway.
-
Non-muscle-invasive bladder cancer (Ta, T1, CIS)
The commonest presentation — confined to the mucosa or lamina propria.
-
Muscle-invasive bladder cancer (T2+)
Tumour has invaded the detrusor muscle — triggers a radical pathway.
-
Carcinoma in situ
High-grade flat disease that mandates intravesical BCG.
-
Grade of tumour (low vs high)
Histological grade drives recurrence risk and adjuvant therapy.
-
Depth of invasion
The single most important prognostic variable — TURBT must include detrusor.
-
Multifocality
Multiple sites within the bladder change the surveillance schedule.
-
Lymphovascular invasion
A high-risk feature that upstages management even in NMIBC.
-
Red flag: high-grade or muscle-invasive disease — urgent cystectomy / oncology pathway
Immediate MDT referral with staging CT and clinical oncology input.
Next steps
What happens after the biopsy.
The histology sets the risk category — non-muscle-invasive disease is managed intravesically, muscle-invasive disease triggers a radical pathway.
-
Single-dose post-TURBT intravesical mitomycin
A one-off chemotherapy instillation within 24 hours reduces recurrence.
-
Repeat TURBT at 6 weeks for high-risk T1
A second-look resection ensures complete removal and accurate staging.
-
Intravesical BCG for high-risk NMIBC
Immunotherapy course to reduce recurrence and progression.
-
Radical cystectomy for muscle-invasive disease
Bladder removal with urinary diversion — the standard curative option.
-
Neoadjuvant chemotherapy
Cisplatin-based regimen before cystectomy for eligible patients.
-
Bladder-preserving chemoradiotherapy
A curative alternative to cystectomy in selected patients.
-
Surveillance cystoscopy schedule
Risk-stratified follow-up cystoscopies to detect recurrence early.
-
Multi-disciplinary team review
Urology, oncology, radiology and pathology decide the plan together.
Red flags
Findings and complications that trigger an urgent pathway.
Any of these features escalate the case immediately — either at the pathology MDT or with your urology consultant on the day.
-
Muscle-invasive bladder cancer
-
Metastatic disease at diagnosis
-
Hydronephrosis
-
Chemical cystitis post-mitomycin
-
Post-TURBT bladder perforation
-
Post-op UTI / sepsis
-
Recurrent haematuria
-
Post-BCG intolerance
-
Concomitant upper-tract urothelial cancer
Reading your report
A bladder biopsy report can look intimidating. It isn’t.
Whatever the finding, the histopathology report keeps to the same four parts.
A quiet reminder
The report is written for your doctor, not for you — and that’s normal.
If you would like us to talk you through it before your follow-up, just ask.
- 01 Header
Indication and clinical background
Your details, the reason for the procedure, and the symptoms (usually haematuria) that led here.
- 02 Technique
Cystoscopy, biopsy and resection
Anaesthetic, rigid cystoscopy findings, cold-cup biopsy sites and any TURBT performed.
- 03 Findings
Tumour histology, grade and depth
Urothelial vs variant histology, WHO grade, depth of invasion and lymphovascular status.
- 04 Impression
The conclusion: read this first
T-stage, risk stratification (NMIBC vs MIBC) and the concrete next step.
Recognised by major UK insurers
Cover depends on your policy and clinic; we confirm with your insurer before booking.
Frequently asked
Everything we get asked about bladder biopsy.
Quick answers on cold-cup vs TURBT, anaesthetic, mitomycin, repeat resection and turnaround.
-
What is a bladder biopsy?
A bladder biopsy is a sample of bladder tissue taken under rigid cystoscopy. It can be a small cold-cup forceps biopsy of a suspicious flat area, or a full transurethral resection of a visible tumour (TURBT). It is the diagnostic test for bladder cancer.
-
What is the difference between a cold-cup biopsy and a TURBT?
A cold-cup biopsy uses forceps to sample a small area — usually a flat, red patch that might be carcinoma in situ. A TURBT uses an electrical loop to resect a whole visible tumour, giving both the diagnosis and the initial treatment. The specimen from a TURBT includes detrusor muscle, which is essential for staging.
-
Do I need a general anaesthetic?
Rigid cystoscopy with biopsy or TURBT is done under general or spinal anaesthetic. It is a day-case procedure for most patients, with a catheter left in overnight and removed the next morning.
-
Why do I get mitomycin after a TURBT?
A single dose of intravesical mitomycin chemotherapy within 24 hours of TURBT roughly halves the risk of recurrence for non-muscle-invasive bladder cancer. It is the standard of care in NICE and EAU guidelines for eligible tumours.
-
When would I need a repeat TURBT?
A second-look TURBT at 4–6 weeks is recommended for high-risk T1 tumours, incomplete initial resection, or when no detrusor muscle was in the specimen. It ensures complete removal and accurate staging before starting BCG.
-
How quickly will I get the results?
Histology is usually back within 7–10 days. Your urologist will discuss the T-stage, grade and risk category with you at a follow-up appointment, and the case is reviewed at the bladder-cancer multi-disciplinary team meeting.
Sources
Clinical references.
- NICE. Bladder cancer: diagnosis and management (NG2).
- European Association of Urology. Guidelines on Bladder Cancer.
- British Association of Urological Surgeons. Patient information.
- American Urological Association. Bladder cancer clinical guidelines.
Reviewed by Pulse Atlas Editorial Board () · Published 2026-07-30 · Next review 2027-07-30 · 7-minute read.
Related tests
Looking for a different test?
-
Cystoscopy
Flexible or rigid look inside the bladder — the first step in haematuria work-up.
Learn more -
Bladder cancer
Condition guide — diagnosis, staging and treatment pathways.
Learn more -
MRI pelvis
Cross-sectional staging when muscle invasion is suspected.
Learn more -
All tests
Browse every test and procedure we arrange.
Learn more -
Prostate Enlargement BPH
Related condition guide.
Learn more -
Kidney Disease CKD
Related condition guide.
Learn more -
Cystectomy
Related treatment option.
Learn more -
Cystoplasty
Related treatment option.
Learn more
In practice, in London
Booking bladder biopsy privately in London — what actually happens
With bladder biopsy, the London question is usually about report turnaround and the radiologist reading it — not whether the scan is available. On the NHS, bladder biopsy typically sits behind a triage step and a wait that can stretch from a few weeks into months. In London’s private sector, the same appointment often lands within days. That speed matters when symptoms are disrupting work, sleep, or a plan you’d already committed to — and it’s the single most common reason people call us in the first place.
In practice, a private bladder biopsy appointment in London means a named consultant, a proper hour in the room (or the equivalent on a video call), and a report you can actually read. Most of the imaging suites and endoscopy units we use sit within a mile of Harley Street or in Chelsea and Fulham, and turnaround on findings is measured in days, not weeks. For bladder biopsy specifically, the difference between a routine report and a sub-speciality read is where private care earns its keep.
We’re careful about what a private pathway for bladder biopsy can and can’t promise. It can compress a wait, put you in front of a subspecialist quickly, and get a proper report in your hands within a week. It can’t rewrite what the imaging or the bloods say. Setting that expectation up front tends to make the whole experience less stressful.